
These 4 Exercises May Be Key to a Good Night's Sleep
Scientists in China reviewed existing clinical trial data and found that certain forms of exercise, including yoga and jogging, that appeared to help people sleep longer at night. The findings suggest physical activity should be considered as a frontline treatment for insomnia, the researchers said.
'The most important takeaway from this research is that we can confidently tell people with insomnia, 'Exercise really can help you sleep better,'' lead study author Zhi-jun Bu told Gizmodo.
Bu and his colleagues were inspired by the idea of 'green prescriptions,' which are essentially interventions for physical and mental health that involve exercise or nutrition. They focused on insomnia because it's both common and debilitating. More than half of American adults are believed to have experienced difficulty sleeping, while a recent survey from the American Academy of Sleep Medicine found that 12% of U.S. adults have been diagnosed with chronic insomnia.
Eating Dairy Before Bed Can Give You Nightmares, Study Suggests
The researchers analyzed data from 22 clinical trials involving more than 1,300 participants and 13 different interventions for insomnia, including cognitive-behavioral therapy, seven forms of exercise, and so-called active controls, like stretching or being given lifestyle advice.
As the researchers had expected, people who received CBT saw significant improvements in their sleep quality and duration, as did those who practiced Tai Chi, yoga, and walking or jogging. Of these, yoga was linked to almost two hours of extra sleep compared to controls, while walking or jogging was tied to a significant reduction in the severity of people's self-reported symptoms. And Tai Chi apparently provided the most benefits for sleep of all the exercises tested.
The findings were published Tuesday in the journal BMJ Evidence-Based Medicine. Bu conducted the study while a researcher at the Beijing University of Chinese Medicine's Center for Evidence-Based Chinese Medicine; he's now pursuing a doctorate at The Affiliated Hospital and Clinical Medical College of Nanjing University of Chinese Medicine.
The analysis is promising, but it has limitations. Some of the trials included were of lower quality than others. But there is other evidence to suggest that exercise can promote rest; a study published earlier this month found that daily exercise was associated with deeper, more restorative sleep. It's also unclear why physical activity can help us doze off, but the researchers have some theories.
'Yoga incorporates breath control and meditation, which helps regulate the autonomic nervous system and reduce anxiety and stress. Tai Chi, as a mind-body practice combining physical movement and mental focus, may enhance parasympathetic activity, reduce inflammatory responses, and promote brain plasticity and circadian rhythm regulation,' Bu explained.
'Aerobic exercises such as walking or jogging may improve sleep structure by increasing energy expenditure, enhancing melatonin secretion, lowering cortisol levels, and boosting the proportion of deep sleep,' he added.
Barely Sleep and Still Feel Fine? Thank Your Lucky Genes
Other questions remain unanswered: There's no established optimal 'dose' of physical activity for insomnia, and the timing of our exercise could be crucial, too. A study published in April found that performing intense workouts up to four hours before bed could disrupt sleep, for example. Some individuals might also benefit most from specific forms of exercise. Yoga and Tai Chi might be best for people who don't sleep enough, while aerobic exercise might work best to reduce people's daytime sleepiness and fatigue, Bu said.
'Overall, exercise is a natural sleep aid with low side effects, low costs, and high accessibility, making it especially suitable for promotion in primary healthcare and community health settings,' Bu said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
24 minutes ago
- Medscape
Fact or Fiction: Bladder Cancer
Recent advances in immunotherapy, genomic profiling, and bladder-sparing techniques have begun to reshape diagnostic algorithms and treatment strategies across disease stages, from non-muscle-invasive to metastatic bladder cancer. Immunotherapies targeting PD-1 and PD-L1 have shown durable responses in certain subsets of patients, while next-generation sequencing helps guide decisions by identifying actionable mutations and molecular subtypes. Additionally, minimally invasive surgical techniques, improvements in intravesical therapies, and novel surveillance tools such as urinary biomarkers contribute to a more personalized, risk-adapted approach. As the field moves toward more integrated, multidisciplinary care, clinicians and care teams must stay abreast of these innovations to ensure optimal outcomes, improved quality of life, and equitable access to cutting-edge therapies. Checkpoint inhibitors such as atezolizumab, nivolumab, and pembrolizumab have been approved for patients with advanced or metastatic urothelial carcinoma, especially those ineligible for cisplatin-based chemotherapy or with disease progression after platinum therapy. These agents work by targeting PD-1 or PD-L1 pathways to enhance the immune system's ability to fight cancer. In recent years, nivolumab was approved for use in combination with cisplatin and gemcitabine as first-line treatment for unresectable or metastatic urothelial carcinoma, marking a major shift toward integrating immunotherapy earlier in treatment algorithms. Learn more about immunotherapy for bladder cancer. Cigarette smoking is the leading risk factor for bladder cancer, responsible for approximately 50% of all cases. Smokers are twice as likely to develop bladder cancer than nonsmokers. Smoking cessation significantly reduces risk over time, though former smokers remain at elevated risk compared to never-smokers. Occupational exposures, such as to benzidine and beta-naphthylamine, are also important, especially for long-term workers in underregulated environments. However, these exposures account for a smaller percentage of overall cases. Environmental exposures are increasingly being realized as a cause for bladder cancer. Pesticides and contaminated drinking water are concerns. Learn more about bladder cancer etiology. The majority of NMIBC cases are managed conservatively, starting with transurethral resection of bladder tumor (TURBT). At recurrence, however, intravesical therapy with instilled chemotherapy drugs, Bacillus Calmette-Guérin (BCG), and immediate radical cystectomy are options that should be discussed. Radical cystectomy is generally reserved for patients who are unresponsive to or who have high-grade T1 lesions with associated carcinoma in situ, lymphovascular invasion, or variant histology. Bladder preservation is a cornerstone of treatment for low- and intermediate-risk patients with NMIBC, aiming to maintain quality of life while achieving cancer control. Surveillance through periodic cystoscopy and urinary cytology is essential to detect recurrences, which are common. Learn more about treatment for NMIBC. Although several urinary biomarkers (eg, NMP22, UroVysion FISH, Cxbladder, bladder tumor antigen tests) are available, they have not replaced cystoscopy, which remains the cornerstone of surveillance. Cystoscopy provides direct visualization and allows for resection of visible tumors, whereas biomarkers have variable sensitivity and specificity with the potential for false positives. Urinary biomarkers are being incorporated as adjuncts to traditional surveillance, however, as they offer minimal discomfort and invasiveness for patients. Ongoing research is exploring novel biomarker panels and genomic assays to better personalize surveillance regimens and reduce the burden of routine cystoscopy without compromising oncologic safety. Learn more about long-term monitoring for bladder cancer. Neoadjuvant cisplatin-based chemotherapy, typically gemcitabine plus cisplatin (GC) or methotrexate-vinblastine-doxorubicin-cisplatin (MVAC), has been shown to improve overall survival, with some studies finding a 10% benefit in 5-year survival. As a result, neoadjuvant chemotherapy is considered a standard of care for eligible patients with muscle-invasive bladder cancer. For cisplatin-ineligible patients, ongoing trials are evaluating alternative treatment options in the neoadjuvant setting. Molecular subtyping, while there is not yet currently sufficient evidence to be the standard of care, may help to inform treatment decision-making and offer the potential for more targeted therapies. Learn more about neoadjuvant therapy for bladder cancer.


Medscape
24 minutes ago
- Medscape
Rapid Review Quiz: Advanced and Metastatic Renal Cell Carcinoma
Advanced and metastatic renal cell carcinoma (RCC) remains a complex and clinically significant disease that often presents diagnostic and therapeutic challenges. Whereas early-stage RCC can be curable with surgery, advanced RCC frequently carries a poor prognosis and demands nuanced, multidisciplinary management. Rapid advancements in systemic therapies, particularly immunotherapy and targeted agents, have transformed the treatment landscape, making ongoing clinical familiarity essential. Understanding current approaches to diagnosis, prognostication, and treatment selection is critical for optimizing outcomes in this evolving field. Patients with metastatic RCC have a 5-year survival rate of 17.4%. This contrasts greatly with the 5-year survival rate of 92.9% among patients with localized RCC. The overall 5-year survival rate in RCC is 78.6%, highlighting the dramatic impact of disease stage on long-term outcomes. Learn more about prognosis of RCC. The most common type of bone metastasis in RCC is osteolytic, resulting from bone resorption due to osteoclast activity. These lesions lead to bone destruction and are frequently associated with complications such as fractures. Osteoblastic lesions, characterized by excessive bone deposition, are associated with other types of cancer but are not commonly seen in RCC. Osteoblastic lesions are a type of sclerotic lesion. Learn more about imaging in RCC. A robust T-cell-mediated antitumor response requires activation of the local interferon gamma signaling pathway within the tumor microenvironment. Adaptive resistance to ICI therapy in RCC is largely attributed to an impaired response to interferon gamma, a key cytokine in anti-tumor immunity. The release of immunosuppressive cytokines can also contribute to resistance by dampening T-cell activity. However, resistance is not caused by a lack of immunosuppressive cells in the tumor microenvironment. On the contrary, regulatory T cells and myeloid-derived suppressor cells often accumulate in the tumor microenvironment and inhibit effective immune responses. Learn more about PD-1/PD-L1 inhibitors for RCC. CAR-T therapy has reshaped therapeutic approaches in several hematologic cancers, but its effectiveness in solid tumors such as RCC remains limited. This relatively reduced effectiveness is largely due to poor CAR T-cell infiltration into solid tumors and an immunosuppressive tumor microenvironment that impairs CAR-T activity. CAR-T therapies are still investigational in RCC, with no FDA-approved treatments currently available. Cytokine release syndrome (CRS) is one of the most common and clinically significant toxicities associated with CAR-T therapy. It is caused by elevated levels of inflammatory cytokines and may present with fever, myalgia, and arthralgia. In severe cases, CRS can lead to endothelial activation and disruption of the blood-brain barrier. Learn more about experimental therapeutic approaches for RCC. NCCN guidelines recommend initiating systemic therapy in patients with either extensive distant metastases or tumors containing a substantial sarcomatoid component before considering cytoreductive nephrectomy. Thermal ablation is typically reserved for select patients with stage T1 disease. Stereotactic body radiation therapy, another form of ablative therapy, may be appropriate for localized (stage I, II, or III) renal cancer in patients who are not ideal candidates for surgery. Current guidelines from the American Society of Clinical Oncology are aligned with these NCCN recommendations, stating that first-line treatment for patients with metastatic RCC exhibiting sarcomatoid features should be systemic therapy, specifically an ICI-based combination. This therapy may consist of ipilimumab plus nivolumab, or alternatively, an ICI paired with a tyrosine kinase inhibitor. Learn more about radiation therapy for RCC.
Yahoo
25 minutes ago
- Yahoo
Experts Reveal 22 Weird Symptoms Women Over 40 Experience—and What They Mean
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." As you get older, your body changes. And you might start to experience unexpected symptoms. Sure, thinning hair and hot flashes are par for the course during your menopause years. But what if you suddenly have trouble sleeping or start feeling cold all the time? How do you know if what you're experiencing is no big deal—or worth mentioning to your doctor, stat? Sometimes, these symptoms are just signs of getting older. Aging offers all kinds of upsides, but it sneaks in some pesky surprises as well. Other times, they may signal a more serious health condition and warrant additional testing to understand what's going on. Here, experts share 22 weird health symptoms women over 40 often experience. They also decode exactly what those symptoms mean, so you know what next steps to take if you relate to anything on the Gain After 40, your metabolism tends to slow down about 5% every decade. This makes it harder to lose weight and easier to gain weight—meaning you have to be more intentional about diet and exercise. 'As your metabolism changes, your portion size and activity level play a much more significant factor in weight maintenance and weight loss,' explains Jessica Shepherd, M.D., a board-certified OB/GYN. 'The decrease in estrogen during menopause causes changes in metabolism, hormone maintenance, and heart health.'Exhaustion Feeling tired is nothing new. But as you age, you may get worn out faster. This is often due to hormonal changes from menopause, but since it's associated with a range of other health conditions, it's worth mentioning to your doctor. In the meantime, do what you can to get enough sleep. Taz Bhatia, M.D., a board-certified integrative medicine physician and women's health expert, recommends 7 hours a night at least 5 nights a week. 'Consistent sleep is a key factor in rejuvenating and replenishing the body,' she Pain Aches and pains happen, especially as you age. But if you experience pain in your chest, neck, jaw, upper stomach, or back—especially with fatigue, nausea, or shortness of breath—talk to your doctor. These could be signs of cardiovascular disease. 'This is the most common cause of death in American women,' says Kecia Gaither, M.D., a board-certified OB/GYN and women's health expert. She recommends getting routine cardiovascular exams to catch the condition Sex Drive Many women in their 40s experience a low sex drive. And everything from hormonal changes to vaginal dryness could be the cause. Often, the solution is as simple as using an estrogen cream. But be sure to mention the symptom to your doctor, especially if it's impacting your quality of Breasts When you turn 40, it's time to start getting routine mammograms. But be on the lookout for common breast cancer symptoms between annual exams. 'Breast and cervical cancer are the two most common cancers affecting women,' Dr. Gaither says. While it's often normal to have swollen breasts before your period, breast swelling, pain, dimpling, or discharge can also be signs of breast The older you get, the more likely you are to develop high blood pressure, or hypertension. The condition often presents without any symptoms. But in some cases, you may experience headaches, nosebleeds, or shortness of breath. Be sure to flag any of these symptoms to your doctor, in addition to getting your blood pressure checked at your annual Sleeping Struggling with insomnia? You're not alone. One study found that 20% of women aged 40-59 had trouble sleeping at least four nights a week. The culprit was thought to be menopause, because night sweats, hot flashes, and mood swings can all affect your sleep Cramps Bloating, gas, and stomach cramps can occur for a variety of reasons. But if they start getting more common in your 40s, it's probably because of—you guessed it—hormones. If you often experience digestive issues or stomach cramps when you're on your period, you may experience the same thing during menopause. But since abdominal cramps are linked with many other health conditions, it's worth mentioning the symptom to your Constantly If you constantly find yourself chugging water and running to the bathroom, you may want to mention it to a doctor. Increased thirst and urination can be signs of diabetes, especially if you're experiencing fatigue and weakness too. As you age, your risk of developing type II diabetes increases, and being overweight makes the condition more likely, says Dr. Hair Hair loss is mainly hereditary for both men and women, but hormones can play a role as well. Menopause often causes your estrogen levels to drop, making your hair thin, fall out, or take on a new texture. Talk to your doctor if you're concerned. They may be able to recommend a supplement or some other kind of Periods Although it sounds counterintuitive, heavy periods are actually a sign of menopause. Your fluctuating hormones can throw off your menstrual schedule, causing some of your periods to be heavier and last longer than Cold All the Time If you're sweating less and struggling to stay warm, bring it up with your doctor—these could be signs of thyroid dysfunction. 'Thyroid dysfunction is the most common hormonal imbalance in women,' Dr. Shepherd explains. Other symptoms include dry skin, thinning hair, fatigue, and weight Swings Women often deal with mood swings from puberty. But as menopause creeps up, the hormonal changes—and emotions that accompany them—can feel unbearable. Dr. Bhatia says learning how to manage stress is essential to maintaining your quality of life. 'Stress drives cortisol, which drives disease,' she says. 'Managing stress … is a skill that everyone needs to learn and practice to stay healthy.'Vaginal Dryness Caused by low levels of estrogen, vaginal dryness is incredibly common during middle age. If the dryness is bothering you, talk to your doctor. They can help you avoid products that cause irritation, and they may even recommend a prescription estrogen or Depression If you're feeling worried, upset, or unlike yourself, mention it to your doctor. Your symptoms may be the result of hormonal changes during menopause, or they could signal a mental health condition, like anxiety or depression. Other conditions, like Alzheimer's, can also cause you to feel anxious or depressed, Dr. Gaither Bones Women tend to lose bone density over time, which can lead to osteoporosis—a condition where your bones become weak and brittle. This makes your bones fragile and easy to break. And since osteoporosis often progresses without symptoms, a fracture or break may be the first sign you have Fog If you're struggling to concentrate and generally feeling out of it, you may have menopause to thank. But because brain fog is associated with a range of health conditions, it's worth mentioning your brain fog to your doctor—especially if it's Seeing or Hearing As you get older, you may not see or hear as well as you used to. That doesn't necessarily mean anything dire, but it's still worth mentioning to your doctor. Getting your sight and hearing checked annually is a great way to adapt to your changing needs and set yourself up for Between Periods Spotting between periods isn't unusual during menopause. But it can also be a sign of cervical cancer, one of the most common cancers affecting women. Other symptoms of cervical cancer include pelvic pain, discomfort during sex, and unusual discharge. Dr. Shepherd, Dr. Bhatia, and Dr. Gaither all recommend getting routine pap smears. And be sure to mention anything unusual to your Flashes Suddenly feeling your skin flush, your palms get sweaty, and your face turn red is never fun. But hot flashes are a very normal part of menopause. About 75% of women experience them. And in some cases, they can cause your heart to race or make you feel dizzy. If your hot flashes last more than a few minutes or you consistently feel overheated, talk to your doctor—trouble cooling down can be a symptom of thyroid or Constipation While the occasional bout of diarrhea or constipation is probably nothing to worry about, experiencing either for more than a few days can be a sign of colorectal cancer. Since routine colonoscopies aren't usually recommended until you turn 50, it's worth mentioning concerning GI symptoms to your doctor any time you experience Sick All the Time If you feel like you're getting sick more than usual, you may not be imagining it. Our immune systems tend to grow weaker as we age, making us more likely to catch common colds and other infections. You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50 Solve the daily Crossword